Clinical Trial Update: Radiolabel Study In Healthy Volunteers For Insomnia-Targeting Drug [Phase 1]

View source ↗

Summary

The document reports the completion of a Phase 1 radiolabel study in healthy volunteers for an insomnia-targeting drug.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia

Drugs mentioned

• Unnamed insomnia-targeting drug

Snippet

Sponsor: GlaxoSmithKline | Conditions: Sleep Initiation and Maintenance Disorders | Phase 1 | Status: COMPLETED